Welcome to Paid Research Studies




  • Condition:   Hearing Loss
    Intervention:   Device: hearing aids
    Sponsor:   VA Office of Research and Development
    Not yet recruiting - verified September 2017

  • Condition:   Sudden Sensorineural Hearing Loss (SSNHL)
    Interventions:   Drug: Dexamethasone;   Drug: Prednisone
    Sponsor:   University of Colorado, Denver
    Recruiting - verified September 2017

  • Condition:   Hearing Loss
    Intervention:   Behavioral: community health worker-audiologist communication education and support group
    Sponsors:   University of Arizona;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified August 2017

  • Conditions:   Acoustic Neuroma;   Labyrinthitis Ossificans;   Profound Hearing Impairment
    Intervention:   Device: MedEl Test Electrode Placer
    Sponsors:   Eric W. Sargent, MD;   Med-El Corporation
    Recruiting - verified August 2017

  • Condition:   Deafness, Bilateral
    Interventions:   Behavioral: Parent-Child Early Approaches to Raising Language Skills;   Other: Standard Care Speech therapy
    Sponsors:   University of Miami;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified August 2017

  • Conditions:   Head and Neck Cancer;   Hearing Disorder;   Hyperlipidemia
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified July 18, 2017

  • Conditions:   Migraine Disorders;   Photophobia;   Phonophobia;   Acute Migraine
    Interventions:   Drug: Rimegepant;   Drug: Placebo
    Sponsor:   Biohaven Pharmaceutical Holding Company Ltd.
    Recruiting - verified September 2017

  • Condition:   Hearing Loss
    Interventions:   Device: Phase I - Standard Microphone Cros Input;   Device: Phase II - Automatic directional microphone Cros Input;   Device: Phase III - No Cros Input
    Sponsor:   University of Miami
    Recruiting - verified August 2017

  • Conditions:   Migraine;   Acute Migraine;   Phonophobia;   Photophobia
    Interventions:   Drug: BHV-3000;   Drug: Placebo Oral Tablet
    Sponsor:   Biohaven Pharmaceutical Holding Company Ltd.
    Recruiting - verified September 2017

  • Conditions:   Sensory Disorders;   Autism;   Autism Spectrum Disorder;   Autism With High Cognitive Abilities;   Autistic Behavior;   Hyperacusis
    Interventions:   Behavioral: Exposure therapy;   Behavioral: Psycho-education;   Behavioral: Caregiver education/home program development
    Sponsor:   University of Florida
    Not yet recruiting - verified July 2017

  • Conditions:   Hearing Loss;   Deafness
    Interventions:   Behavioral: Aural Rehabilitation Group;   Behavioral: Cognitive Training Group
    Sponsors:   Gallaudet University;   Columbia University;   The Cleveland Clinic
    Recruiting - verified May 2017

  • Conditions:   Implants, Cochlear;   Child;   Hearing Loss, Bilateral
    Intervention:   Device: Hybrid L24
    Sponsor:   Bruce J Gantz
    Recruiting - verified May 2017

  • Conditions:   Usher Syndrome, Type 2A;   Retinitis Pigmentosa 39
    Intervention:  
    Sponsors:   Jaeb Center for Health Research;   Foundation Fighting Blindness;   Duke University;   Oregon Health and Science University
    Recruiting - verified June 2017

  • Conditions:   Hearing Loss;   Health Literacy
    Intervention:   Other: Health Information Assessment
    Sponsors:   University of Michigan;   Rochester Institute of Technology;   Sinai Health System;   Hurley Medical Center;   Boston University
    Recruiting - verified March 2017

  • Conditions:   Cmv Congenital;   CMV;   Congenital Cmv;   SNHL;   Sensorineural Hearing Loss
    Interventions:   Drug: Valganciclovir;   Drug: Simple Syrup
    Sponsors:   Albert Park;   National Institute on Deafness and Other Communication Disorders (NIDCD);   Genentech, Inc.
    Not yet recruiting - verified April 2017

  • Conditions:   Deafness; Sensoneural Single Sided;   Conductive Hearing Loss;   Mixed Hearing Loss
    Intervention:   Device: Osia System
    Sponsor:   Cochlear Bone Anchored Solutions
    Recruiting - verified June 2017

  • Condition:   Hearing Loss
    Intervention:   Device: PockeTalker" Hearing Assistive Device (HAD)
    Sponsor:   New York University School of Medicine
    Recruiting - verified May 2017

  • Conditions:   Congenital Fibrosis of Extraocular Muscles;   Duane Retraction Syndrome;   Duane Radial Ray Syndrome;   Mobius Syndrome;   Brown Syndrome;   Marcus Gunn Syndrome;   Strabismus Congenital;   Horizontal Gaze Palsy;   Horizontal Gaze Palsy With Progressive Scoliosis;   Facial Palsy;   Facial Paresis, Hereditary, Congenital;   Third Nerve Palsy;   Fourth Nerve Palsy;   Sixth Nerve Palsy;   Synkinesis;   Ocular Motility Disorders;   Levator-Medial Rectus Synkinesis;   Athabaskan Brainstem Dysgenesis;   Tongue Paralysis;   Ninth Nerve Disorder;   Fifth Nerve Palsy;   Seventh Nerve Palsy;   Eleventh Nerve Disorder;   Twelfth Nerve Disorder;   Vagus Nerve Paralysis;   Moebius Sequence
    Intervention:  
    Sponsors:   Boston Children’s Hospital;   Howard Hughes Medical Institute;   National Eye Institute (NEI)
    Recruiting - verified February 2017

  • Condition:   Concussion, Mild
    Intervention:   Device: Q collar
    Sponsor:   Children's Hospital Medical Center, Cincinnati
    Recruiting - verified January 2017

  • Condition:   Tinnitus
    Interventions:   Device: Desyncra;   Other: Cognitive Behavioral Therapy
    Sponsors:   VA National Center for Rehabilitative Auditory Research;   Desyncra, Inc.
    Recruiting - verified March 2017

  • Condition:   Hearing Loss
    Intervention:   Other: Family Medicine Hearing Loss Best Practice Alert
    Sponsor:   University of Michigan
    Recruiting - verified December 2016

  • Condition:   Hearing Loss, Sensorineural
    Interventions:   Device: CI532;   Device: Nucleus 7
    Sponsor:   Cochlear
    Recruiting - verified September 2017

  • Conditions:   Hearing Loss;   Language Development;   Social Behavior
    Interventions:   Behavioral: augmentative and alternative communication technology;   Behavioral: Usual Care
    Sponsor:   Children's Hospital Medical Center, Cincinnati
    Recruiting - verified December 2016

  • Condition:   Hearing Loss, Unilateral
    Intervention:   Device: Cochlear implant
    Sponsors:   University of North Carolina, Chapel Hill;   Med-El Corporation
    Recruiting - verified September 2017

  • Condition:   Focus of the Study is to Promote Healthy Hearing
    Interventions:   Other: Noisy City information about hearing health care;   Other: Generic Game
    Sponsors:   Photozig, Inc.;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified October 2016

  • Conditions:   Hearing Loss;   Geriatric Disorder
    Interventions:   Other: Tele-HS;   Other: PCP encouragement
    Sponsors:   Duke University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified October 2016

  • Condition:   Autoimmune Neurosensory Hearing Loss (ANSHL)
    Intervention:   Drug: Rilonacept
    Sponsors:   Stanley Cohen;   Regeneron Pharmaceuticals
    Recruiting - verified September 2017

  • Conditions:   Metabolism, Inborn Errors;   Hearing Loss;   Hereditary Disease
    Interventions:   Genetic: Well infant, whole exome sequencing;   Genetic: Diagnosed, whole exome sequencing
    Sponsors:   University of North Carolina, Chapel Hill;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Human Genome Research Institute (NHGRI);   RTI International
    Recruiting - verified September 2017

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsor:   Washington University School of Medicine
    Recruiting - verified March 2017

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
    Intervention:  
    Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
    Recruiting - verified July 2016

  • Condition:   Hearing Loss, Idiopathic Sudden Sensorineural
    Interventions:   Drug: AM-111 0.4 mg/ml;   Drug: AM-111 0.8 mg/ml;   Other: Placebo
    Sponsor:   Auris Medical, Inc.
    Recruiting - verified September 2017

  • Condition:   Tinnitus
    Interventions:   Device: Neuromonics Tinnitus Treatment Program;   Device: Placebo Device
    Sponsors:   United States Army Aeromedical Research Laboratory;   Congressionally Directed Medical Research Programs
    Recruiting - verified May 2017

  • Conditions:   Hearing Loss;   Ear Diseases;   Hearing Disorders;   Otorhinolaryngologic Diseases;   Asymmetrical Hearing Loss;   Single-Sided Deafness
    Intervention:   Device: HiResolution Bionic Cochlear Implant
    Sponsor:   Advanced Bionics
    Recruiting - verified October 2016

  • Condition:   Hearing Loss
    Interventions:   Behavioral: standard hearing aid fitting;   Behavioral: coupler-based fitting;   Behavioral: coupler-based fitting
    Sponsor:   VA Office of Research and Development
    Recruiting - verified May 2017

  • Condition:   Hearing Impairment
    Intervention:   Device: NEATCAP
    Sponsor:   University of Pittsburgh
    Recruiting - verified May 2017

  • Condition:   Sensorineural Hearing Loss, Bilateral
    Intervention:   Device: Cochlear Nucleus CI532
    Sponsor:   Cochlear
    Recruiting - verified February 2017

  • Condition:   Hearing Loss
    Interventions:   Procedure: Hum Test;   Procedure: Weber Test;   Device: Audiogram
    Sponsor:   New York University School of Medicine
    Recruiting - verified October 2016

  • Conditions:   Tinnitus;   Pulsatile Tinnitus;   Venous Sinus Stenosis;   Dural Sinus Stenosis
    Intervention:   Device: Venous Sinus Stenting
    Sponsor:   Weill Medical College of Cornell University
    Recruiting - verified January 2017

  • Conditions:   Articulation Disorder;   Dysarthria;   Prelingual Deafness
    Intervention:   Device: Opti-Speech
    Sponsors:   Vulintus, Inc.;   National Institute on Deafness and Other Communication Disorders (NIDCD);   Callier Center for Communication Disorders;   Cleveland Hearing and Speech Center;   Case Western Reserve University
    Recruiting - verified October 2016

  • Conditions:   Total Unilateral Deafness;   Unilateral Partial Deafness
    Intervention:   Device: Med-el MAESTRO Cochlear Implant with Flex 28 electrode array
    Sponsors:   Dr. Daniel Lee;   University of Wisconsin, Madison
    Recruiting - verified August 2017

  • Condition:   Congenital Sensorineural Deafness
    Interventions:   Behavioral: Telemedicine;   Behavioral: In-person ART
    Sponsors:   University of Colorado, Denver;   National Institute on Deafness and Other Communication Disorders (NIDCD);   University of Colorado, Boulder
    Recruiting - verified July 2017

  • Condition:   Deafness
    Intervention:   Procedure: Cochlear implant surgery
    Sponsor:   Mayo Clinic
    Recruiting - verified November 2016

  • Condition:   Tinnitus
    Intervention:   Behavioral: Cognitive behavioral therapy
    Sponsor:   University of California, Irvine
    Recruiting - verified May 2017

  • Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
    Intervention:  
    Sponsor:   Foundation Fighting Blindness Clinical Research Institute
    Recruiting - verified September 2017

  • Conditions:   Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
    Intervention:  
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified October 2016

  • Condition:   High Frequency Sensorineural Hearing Loss
    Intervention:   Device: Nucleus Hybrid L24 Implant
    Sponsor:   Cochlear
    Recruiting - verified March 2017

  • Condition:   Hearing Loss, Bilateral (Causes Other Than Tumors)
    Intervention:   Device: Nucleus ABI541 Auditory Brainstem Implant
    Sponsor:   New York University School of Medicine
    Recruiting - verified October 2016

  • Condition:   Unilateral Hearing Loss
    Intervention:   Device: Hearing aid
    Sponsor:   Massachusetts Eye and Ear Infirmary
    Recruiting - verified April 2017

  • Conditions:   Hearing Loss;   Partial Deafness;   Hearing Disorders;   Ear Diseases;   Otorhinolaryngologic Diseases
    Interventions:   Device: HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode;   Device: EAS sound processor
    Sponsor:   Advanced Bionics
    Recruiting - verified July 2017

  • Conditions:   Mucopolysaccharidosis Disorders;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Alpha-Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Glycoprotein Metabolic Disorders;   Sphingolipidoses;   Recessive Leukodystrophies;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann-Pick B;   Niemann-Pick C Subtype 2;   Sphingomyelin Deficiency;   Peroxisomal Disorders;   Adrenoleukodystrophy With Cerebral Involvement;   Zellweger Syndrome;   Neonatal Adrenoleukodystrophy;   Infantile Refsum Disease;   Acyl-CoA Oxidase Deficiency;   D-Bifunctional Enzyme Deficiency;   Multifunctional Enzyme Deficiency;   Alpha-methylacyl-CoA Racmase Deficiency;   Mitochondrial Neurogastrointestingal Encephalopathy;   Severe Osteopetrosis;   Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation);   Inherited Metabolic Disorders
    Interventions:   Biological: Stem Cell Transplantation;   Drug: IMD Preparative Regimen;   Drug: Osteopetrosis Only Preparative Regimen;   Drug: Osteopetrosis Haploidentical Only Preparative Regimen;   Drug: cALD SR-A (Standard-Risk, Regimen A);   Drug: cALD SR-B (Standard-Risk, Regimen B);   Drug: cALD HR-D (High-Risk, Regimen C);   Drug: cALD HR-D (High-Risk, Regimen D)
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting - verified June 2017

  • Condition:   Bilateral Severe to Profound Hearing Loss
    Intervention:   Drug: CGF166
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified April 2017

  • Conditions:   Hearing Impairment;   Hearing Aid Fitting
    Intervention:   Device: mild-gain hearing aids
    Sponsor:   VA Office of Research and Development
    Recruiting - verified April 2017

  • Condition:   Severe Unilateral Sensorineural Hearing Loss
    Intervention:   Device: Cochlear implant
    Sponsor:   Mayo Clinic
    Recruiting - verified May 2017

  • Conditions:   Neuroectodermal Tumors, Primitive;   Liver Neoplasms;   Neoplasms, Germ Cell and Embryonal;   Osteosarcoma;   Other Childhood Cancers Using Cisplatin-based Regimens
    Intervention:   Drug: N-Acetylcysteine
    Sponsor:   Children's Hospital Los Angeles
    Recruiting - verified October 2016

  • Conditions:   Profound Bilateral Deafness Due to;   Bilateral Cochlear Aplasia;   Bilateral Cochlear Nerve Deficiency;   Bilateral Cochlear Ossification Secondary to Meningitis
    Intervention:   Device: Auditory Brainstem Implant
    Sponsors:   Laurie Eisenberg;   Keck School of Medicine of USC;   Children's Hospital Los Angeles;   Huntington Medical Research Institutes
    Recruiting - verified March 2017

  • Conditions:   Cisplatin Ototoxicity;   Hearing Loss
    Interventions:   Other: COMP-VA;   Other: Standard of care;   Other: Program evaluation
    Sponsor:   VA Office of Research and Development
    Recruiting - verified April 2017

  • Conditions:   Sensorineural Hearing Loss;   Long QT Syndrome
    Intervention:  
    Sponsor:   Mednax Center for Research, Education and Quality
    Recruiting - verified December 2016

  • Condition:   Bilateral Sensorineural Hearing Loss
    Intervention:   Device: Cochlear implant
    Sponsors:   American Cochlear Implant Alliance;   University of Michigan;   University of Iowa;   Johns Hopkins University;   University of Miami;   New York University School of Medicine;   University of North Carolina;   University of Southern California;   Vanderbilt University;   University of Washington;   Washington University School of Medicine;   Loyola University Chicago;   University of Pennsylvania;   University of Texas;   Saint Luke's Health System
    Recruiting - verified June 2017

  • Condition:   Noise-induced Hearing Loss
    Interventions:   Drug: Zonisamide;   Drug: Methylprednisolone
    Sponsor:   Washington University School of Medicine
    Not yet recruiting - verified November 2016

  • Conditions:   Hearing Loss;   Tinnitus
    Interventions:   Other: Screening;   Other: Brochure;   Behavioral: Education
    Sponsor:   University of California, San Francisco
    Recruiting - verified May 2017

  • Condition:   Congenital Hearing Loss
    Interventions:   Behavioral: Patient Navigator;   Behavioral: Standard scheduling and follow-up
    Sponsors:   Matthew Bush, MD;   National Institute on Deafness and Other Communication Disorders (NIDCD);   National Institutes of Health (NIH)
    Recruiting - verified October 2016

  • Condition:   Bilateral Hearing Loss for Causes Other Than Tumors
    Intervention:   Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)
    Sponsor:   Massachusetts Eye and Ear Infirmary
    Recruiting - verified April 2017

  • Condition:   Sensorineural Hearing Loss
    Intervention:  
    Sponsor:   Steward St. Elizabeth's Medical Center of Boston, Inc.
    Recruiting - verified November 2016

  • Conditions:   Smith-Lemli-Opitz Syndrome;   Cone-Rod Dystrophy;   Hearing Loss
    Interventions:   Drug: Antioxidants;   Drug: Cholesterol
    Sponsor:   University of Colorado, Denver
    Recruiting - verified August 2017

  • Condition:   Bilateral Hearing Loss for Causes Other Than Tumors
    Intervention:   Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)
    Sponsor:   Massachusetts Eye and Ear Infirmary
    Recruiting - verified April 2017

  • Conditions:   Presbycusis;   Aging;   Hearing Loss
    Intervention:   Device: hearing aid
    Sponsors:   Indiana University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified June 2017

  • Conditions:   Congenital Cytomegalovirus;   Hearing Loss
    Interventions:   Drug: Valcyte (Valganciclovir hydrochloride) Powder for oral solution;   Drug: Placebo
    Sponsor:   University of Alabama at Birmingham
    Recruiting - verified May 2017

  • Condition:   Healthy Volunteer
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified April 4, 2017

  • Conditions:   Usher Syndrome;   Retinitis Pigmentosa
    Intervention:   Genetic: UshStat
    Sponsor:   Sanofi
    Recruiting - verified March 2017

  • Conditions:   Neurofibromatosis Type 2;   Neuroma, Acoustic
    Intervention:   Drug: RAD001, everolimus
    Sponsors:   Jonsson Comprehensive Cancer Center;   Novartis Pharmaceuticals
    Recruiting - verified April 2017

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma
    Intervention:   Radiation: Fractionated proton radiation
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting - verified July 2017

  • Condition:   Tinnitus
    Interventions:   Device: Repetitive Transcranial Magnetic Stimulation (rTMS) - ACTIVE;   Device: Repetitive Transcranial Magnetic Stimulation (rTMS) - SHAM
    Sponsors:   University of Arkansas;   National Institutes of Health (NIH)
    Recruiting - verified November 2016

  • Conditions:   Craniosynostosis;   Muenke Syndrome
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting - verified August 14, 2017

  • Conditions:   Sensorineural Hearing Loss;   Hearing Disorder;   Vestibular Disease
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified August 22, 2017

  • Conditions:   Sensorineural Hearing Loss;   Cytomegalovirus Infection
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified September 7, 2017